{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:05:17Z","timestamp":1793160317813,"version":"4.5.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The COVID-19 pandemic has resulted in the rapid development of a range of vaccines against SARS-CoV-2. Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a rare but life-threatening complication of primarily adenoviral-based vaccines associated with the presence of antibodies to a PF4\/polyanion neoepitope and measured by using enzyme-linked immunosorbent assays. Presented are serial anti\u2013PF4\/polyanion antibody, platelet, and D-dimer measurements in a large cohort of patients and their relation to relapse. Overall, 51% of patients using the Stago assay had persistently positive anti\u2013PF4\/polyanion levels 100 days\u2019 postdiagnosis, whereas 94% of patients monitored by using the Immucor assay remain positive. The median duration of positivity of the PF4 assay is 87 days, with 72% of patients remaining positive after a median follow-up of 105 days. The use of plasma exchange seemed to reduce anti\u2013PF4\/polyanion levels and increase platelet counts in the acute setting more rapidly than other therapies. The rate of relapse in this study was 12.6%, with all relapsed cases exhibiting persistently positive PF4 antibodies and falling platelet counts. Only one patient had extension of their thrombosis. Overall, despite the persistence of PF4 antibodies in 72% of patients, the rate of relapse was low and did not seem to result in recrudescence of the aggressive clinical picture seen at index presentation. Monitoring of these patients in the UK cohort is ongoing and will aid in definition of the natural history of this novel condition.<\/jats:p>","DOI":"10.1182\/blood.2021014684","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T19:08:51Z","timestamp":1646852931000},"page":"2553-2560","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":36,"title":["Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis"],"prefix":"10.1182","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6420-5318","authenticated-orcid":false,"given":"Brian","family":"Craven","sequence":"first","affiliation":[{"name":"University\u00a0College London Hospitals NHS Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8790-7112","authenticated-orcid":false,"given":"William","family":"Lester","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boyce","sequence":"additional","affiliation":[{"name":"University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Thomas","sequence":"additional","affiliation":[{"name":"Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Kanny","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Davies","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Pavord","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joannes","family":"Hermans","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-7939","authenticated-orcid":false,"given":"Michael","family":"Makris","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Bart-Smith","sequence":"additional","affiliation":[{"name":"Epsom and St. Helier University Hospitals NHS Trust, Epsom, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Arnott","sequence":"additional","affiliation":[{"name":"Medway NHS Foundation Trust, Medway, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4709-0774","authenticated-orcid":false,"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Chudakou","sequence":"additional","affiliation":[{"name":"United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Calvert","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Singh","sequence":"additional","affiliation":[{"name":"University\u00a0College London Hospitals NHS Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Scully","sequence":"additional","affiliation":[{"name":"University\u00a0College London Hospitals NHS Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2022042115224489000_B1","author":"COVID Live\u2013Coronavirus Statistics\u2013Worldometer"},{"issue":"5","key":"2022042115224489000_B2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med."},{"issue":"27","key":"2022042115224489000_B3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"issue":"10269","key":"2022042115224489000_B4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet."},{"key":"2022042115224489000_B5","author":"Coronavirus vaccine\u2013weekly summary of Yellow Card reporting"},{"issue":"23","key":"2022042115224489000_B6","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med."},{"issue":"22","key":"2022042115224489000_B7","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med."},{"issue":"22","key":"2022042115224489000_B8","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med."},{"key":"2022042115224489000_B9","article-title":"Joint CDC and FDA Statement on Johnson & Johnson COVID-19 vaccine","author":"Office of the Commissioner"},{"key":"2022042115224489000_B10","article-title":"MHRA response to JCVI advice on COVID-19 vaccine AstraZeneca for people aged under 40"},{"issue":"18","key":"2022042115224489000_B11","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med."},{"issue":"10306","key":"2022042115224489000_B12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(21)01608-1","article-title":"Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study","volume":"398","author":"Perry","year":"2021","journal-title":"Lancet Lond Engl."},{"key":"2022042115224489000_B13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.thromres.2021.09.017","article-title":"Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia","volume":"207","author":"Thaler","year":"2021","journal-title":"Thromb Res."},{"issue":"26","key":"2022042115224489000_B14","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood.2021012064","article-title":"A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination","volume":"137","author":"Handtke","year":"2021","journal-title":"Blood."},{"issue":"19","key":"2022042115224489000_B15","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMc2112760","article-title":"Decline in pathogenic antibodies over time in VITT","volume":"385","author":"Sch\u00f6nborn","year":"2021","journal-title":"N Engl J Med."},{"issue":"8","key":"2022042115224489000_B16","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/jth.15362","article-title":"Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination","volume":"19","author":"Platton","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"12","key":"2022042115224489000_B17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.2021014214","article-title":"Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient","volume":"139","author":"Sch\u00f6nborn","year":"2022","journal-title":"Blood."},{"issue":"17","key":"2022042115224489000_B18","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med."},{"key":"2022042115224489000_B19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2021.05.018","article-title":"Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","volume":"204","author":"Warkentin","year":"2021","journal-title":"Thromb Res."},{"key":"2022042115224489000_B20","doi-asserted-by":"crossref","first-page":"100067","DOI":"10.1016\/j.tru.2021.100067","article-title":"Long-term anti-PF4 persistence in autoimmune heparin-induced thrombocytopenia: a glimpse into the natural history of vaccine-induced immune thrombotic thrombocytopenia","volume":"5","author":"Roberge","year":"2021","journal-title":"Thromb Update."},{"issue":"6","key":"2022042115224489000_B21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/09537104.2017.1366973","article-title":"Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review","volume":"28","author":"Poudel","year":"2017","journal-title":"Platelets."},{"issue":"4","key":"2022042115224489000_B22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood."},{"issue":"6","key":"2022042115224489000_B23","doi-asserted-by":"crossref","first-page":"e12580","DOI":"10.1002\/rth2.12580","article-title":"Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people after ChAdOx1 nCoV-19 vaccination","volume":"5","author":"Uaprasert","year":"2021","journal-title":"Res Pract Thromb Haemost."},{"issue":"5","key":"2022042115224489000_B24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jca.20143","article-title":"Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures","volume":"22","author":"Shemin","year":"2007","journal-title":"J Clin Apher."},{"issue":"1","key":"2022042115224489000_B25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc2118507","article-title":"VITT and second doses of Covid-19 vaccine","volume":"386","author":"Lacy","year":"2022","journal-title":"N Engl J Med."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/16\/2553\/1892581\/bloodbld2021014684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/16\/2553\/1892581\/bloodbld2021014684.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T15:40:05Z","timestamp":1650555605000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/16\/2553\/484324\/Natural-history-of-PF4-antibodies-in-vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":25,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,4,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021014684","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]}}}